US STOCK
LFST Stock Analysis
US stocks · market data · technical indicators
LifeStance Health Group, Inc.
LFSTUS stocksQuote delayed 15 min
9/12 上午02:17 updated
$13.06
+0.05+0.42%
Open
$13.05
High
$14.15
Low
$12.97
Volume
224.30萬
LFST price history
+6.79%Open
12.22
Latest
13.05
High
13.05
Low
12.15
Average
12.55
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score65
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$13.055
Target Price$15.013
Change %+0.42%
Institutional
Net Selling
Foreign Ownership
Flat
Market Heat
Positive
Fundamentals (US)
P/E Ratio
100.38x
ROE
3.43%
P/B Ratio
3.37x
Dividend Yield
--
Market Insight
The score sits in neutral territory (65/100). Waiting for a clearer signal may be warranted. The target price implies roughly 15.00% upside.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
LFST - LifeStance Health Group, Inc.
EPS
0.13USD
Forward EPS
0.53USD
P/E
100.38x
Forward P/E
24.59x
P/B
3.37x
ROE
3.43%
ROA
2.32%
Operating margin
7.25%
Profit margin
3.19%
Revenue growth
26.10%
Earnings growth
--
Dividend yield
--
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $435.35M | $403.48M | $382.19M | $363.81M | $345.31M | — |
| Gross profit | $153.04M | $135.93M | $126.30M | $116.58M | $108.43M | — |
| Operating income | $30.65M | $22.28M | $18.08M | $7.41M | -$2.95M | — |
| Net income | $23.61M | $14.24M | $11.67M | $1.08M | -$3.79M | — |
| Basic EPS | 0.06 | 0.04 | — | 0.00 | -0.01 | 0.00 |
| Diluted EPS | 0.06 | 0.04 | — | 0.00 | -0.01 | 0.00 |
Estimates vs actuals
Next earnings
2026-11-05
EPS estimate
0.10
Revenue estimate
$431.36M
Last surprise
+32.41%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-05 | 0.10 | Not reported | — |
| 2026-08-06 | 0.08 | 0.11 | +32.41% |
| 2026-05-07 | 0.06 | 0.07 | +10.42% |
| 2026-02-25 | 0.05 | 0.09 | +64.27% |
| 2025-11-06 | 0.04 | 0.01 | -63.67% |
| 2025-08-07 | 0.03 | 0.03 | -0.91% |
| 2025-05-07 | 0.01 | 0.05 | +311.58% |
| 2025-02-27 | — | 0.02 | +501.64% |
| 2024-11-07 | -0.01 | 0.03 | +291.23% |
| 2024-08-08 | -0.01 | 0.01 | +221.62% |
| 2024-05-09 | -0.01 | Not reported | +79.95% |
| 2024-02-28 | -0.01 | -0.02 | -64.48% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $124.6M | 0.00% |
| STATE STREET CORP | 2026-06-30 | $88.1M | 0.00% |
| BlackRock Inc. | 2024-06-30 | $40.9M | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $10.3M | 0.01% |
| CITADEL ADVISORS LLC | 2026-06-30 | $5.5M | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $1.7M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$14.20
Target range
$12.00 – $18.00
Implied upside
8.81%
Strong buy
2
Buy
7
Hold
2
Sell
0
Strong sell
0
Advertisement